This albumin-based particle composition of paclitaxel is the first biologically interactive form of the drug with the potential to exploit a receptor-mediated pathway, allowing increased transport of albumin-bound paclitaxel from blood to tumor [16]. This evidence concerns the gene ALB and neoplasm.